Medicare Enrolled
Dr. Matthew Petitt, DO
Dermatopathology Physician · Pasadena, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Petitt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Petitt?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Petitt
Dr. Matthew Petitt is a dermatopathology physician in Pasadena, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Petitt performed 9,549 Medicare services across 4,970 unique beneficiaries.
Between the years covered by Open Payments, Dr. Petitt received a total of $20,308 from 52 pharmaceutical and/or device companies across 1024 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Petitt is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 16% volume in TX
$20,308 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,549
Medicare services
Top 16% in TX for dermatopathology physician
4,970
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~530 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
4,447 | $57 | $170 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,402 | $5 | $25 |
| Tissue staining for diagnosis, additional An extra laboratory procedure to apply special stains to tissue slides for detailed examination. |
652 | $23 | $47 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
463 | $67 | $152 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
437 | $35 | $111 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
380 | $69 | $175 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
253 | $34 | $96 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
230 | $92 | $215 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
229 | $40 | $89 |
| Tissue staining for diagnosis, initial A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics. |
221 | $28 | $58 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
132 | $85 | $191 |
| Special stain test for organisms A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results. |
122 | $92 | $186 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
82 | $78 | $186 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
47 | $340 | $731 |
| Special tissue stain and interpretation A laboratory test using special stains to examine tissue samples, including the pathologist's review and written report of the findings. |
47 | $68 | $134 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
40 | $127 | $278 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
34 | $108 | $300 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
33 | $1 | $5 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
32 | $102 | $416 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
32 | $119 | $279 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
30 | $388 | $806 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
26 | $304 | $684 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 26 | $110 | $317 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
25 | $83 | $219 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
25 | $112 | $455 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
22 | $56 | $167 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
19 | $117 | $473 |
| Destruction of skin growth, 15 or more growths | 14 | $95 | $224 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $47 | $93 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
12 | $144 | $346 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
11 | $105 | $429 |
| All potassium hydroxide (koh) preparations | 11 | $6 | $7 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$20,308
Total received (2018-2024)
Avg $2,901/year across 7 years
Top 14% in TX for dermatopathology physician
52
Companies
1,024
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,994 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$314 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,297
2023
$4,331
2022
$3,187
2021
$2,408
2020
$2,091
2019
$2,127
2018
$1,866
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$2,108
Novartis Pharmaceuticals Corporation
$1,967
ABBVIE INC.
$1,888
Regeneron Healthcare Solutions, Inc.
$1,288
Lilly USA, LLC
$1,268
GENZYME CORPORATION
$1,080
LEO Pharma Inc.
$1,071
PFIZER INC.
$969
Sun Pharmaceutical Industries Inc.
$829
Amgen Inc.
$827
AbbVie, Inc.
$633
Arcutis Biotherapeutics, Inc.
$546
Incyte Corporation
$502
AbbVie Inc.
$499
Dermavant Sciences, Inc.
$447
UCB, Inc.
$400
Ortho Dermatologics, a division of Bausch Health US, LLC
$380
Galderma Laboratories, L.P.
$373
Organogenesis Inc.
$365
Celgene Corporation
$348
Paratek Pharmaceuticals, Inc.
$302
Almirall LLC
$273
MAYNE PHARMA INC.
$238
Genentech USA, Inc.
$218
Hill Dermaceuticals, Inc.
$213
SUN PHARMACEUTICAL INDUSTRIES INC.
$161
Mayne Pharma Inc.
$140
Encore Dermatology Inc.
$116
DERMIRA, INC.
$114
EPI Health, LLC
$85
Mallinckrodt Hospital Products Inc.
$73
Journey Medical Corporation
$71
Medimetriks Pharmaceuticals, Inc.
$64
VYNE Pharmaceuticals Inc.
$51
Biofrontera Inc.
$44
Tempus AI, Inc
$37
E.R. Squibb & Sons, L.L.C.
$36
DUSA Pharmaceuticals, Inc.
$32
Nabriva Therapeutics, plc
$27
Mylan Pharmaceuticals Inc.
$25
Sebela Pharmaceuticals Inc.
$24
Merck Sharp & Dohme Corporation
$22
ORGANOGENESIS INC.
$20
Teva Pharmaceuticals USA, Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$16
AstraZeneca Pharmaceuticals LP
$15
Melinta Therapeutics, Inc.
$15
Helsinn Therapeutics (U.S.), Inc.
$14
SANOFI-AVENTIS U.S. LLC
$11
Promius Pharma LLC
$11
Aclaris Therapeutics, Inc.
$11
Top 3 companies account for 29.4% of total payments
Associated products mentioned in payments ›
20% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ACTHAR · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Ameluz · BLU-U · BRYHALI · Baxdela · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · Clindacin ETZ · Cordran · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DermOtic · EBGLYSS · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · EVUSHELD · Enbrel · Erivedge · FINACEA · Finacea · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · Klisyri · LEVULAN KERASTICK · LIBTAYO · LITFULO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · Merlin Test · NUZYRA · ODOMZO · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Odomzo · Olux · Otezla · PRAMOSONE · Puraply · Puraply Antimicrobial · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SILIQ · SIMLANDI · SIVEXTRO · SKYRIZI · SOOLANTRA · SORILUX · SPEVIGO · Sernivo Spray · Seysara · Sivextro · Skyrizi · Sotyktu · TALTZ · TREMFYA · TWYNEO · TargaDox · Tremfya · VALCHLOR · VTAMA · Veltin · Winlevi · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $213 per 100 Medicare services performed
Geographic Context
Dermatopathology physicians within 10 mi
14
Per 100K population
0.3
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE SOUTHEAST
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Petitt is a mixed practice specialist, with above-average Medicare volume (top 16% in TX), with low-engagement industry engagement in the top 14% of TX peers, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Petitt experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Petitt performed 4,447 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Petitt receive payments from pharmaceutical companies?
Yes. Dr. Petitt received a total of $20,308 from 52 companies across 1,024 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Petitt's costs compare to other dermatopathology physicians in Pasadena?
Dr. Petitt's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Petitt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatopathology Physicians in Pasadena
Browse dermatopathology physicians in Pasadena ranked by procedure volume and transparency data.
Highest volume
Top Dermatopathology Physicians in TX
Dermatopathology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatopathology Physicians in TX
Which TX dermatopathology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology